DISCOVERY
Uncover breakthrough
innovations during the drug
discovery phase.
innovations during the drug
discovery phase.
Jennifer Murphy has over 20 years of experience in clinical operations and development with expertise in all aspects of clinical project and program management including CRO oversight and vendor management, risk management, site management and monitoring as well as process and quality improvement initiatives (gap analyses, remediation, SOP development and revision, inspection readiness activities) in both industry and academic settings. She has diverse experience working with pharmaceutical, biotechnology, and device companies on a variety of trial designs, trial phases (I-IV), and therapeutic areas (oncology/hematology, immunology, hepatology, infectious diseases, pediatrics, rheumatology, dermatology, neurology, cardiology).
Before joining Halloran, Jennifer worked at Duke Clinical Research Institute for ten years where she managed a variety of phase I-IV industry and government-sponsored clinical projects with a focus on oncology, rheumatology, neurology, and infectious diseases. Previously, she worked at Genmab Inc. where she worked on Phase I-III oncology and rheumatology studies.
